Triple agonist · GLP-1 / GIP / glucagon

Retatrutide

$110 30 mg · per vial
1
For research use only. Not for human consumption.
Route
Subcutaneous
Documentation
On request
Shipping
Discreet
Handling
Inspected on arrival

Studied for its role in appetite regulation and metabolic function via triple-receptor activation. Phase 2 human data showed the largest weight-reduction effect size reported in the class.

Watch
Deep research

Mechanism, common research protocols, evidence review, and cited primary literature for Retatrutide live on the full guide.

Read the guide →